Company Overview
About Ginkgo Bioworks
Ginkgo Bioworks is a synthetic biology platform company that provides cell programming services to the agricultural, pharmaceutical, food, and industrial chemicals industries, helping customers design and manufacture biological products using engineered microorganisms. Founded in 2008 by MIT researchers and headquartered in Boston, Ginkgo went public via SPAC merger in September 2021 at a $15 billion valuation — one of the largest biotech-related SPAC transactions ever.
Business Model & Competitive Advantage
Ginkgo's platform combines automated biology labs (called Foundries), proprietary genetic parts libraries (the Codebase), and data analysis to dramatically reduce the cost and time to engineer cells for industrial applications. Customers pay Ginkgo to design strains that produce target compounds — enzymes, proteins, novel molecules — using a platform fee plus royalty model. The company has collaborated with Bayer (agriculture), Sumitomo Chemical, Ginkgo Crop Protection, and defense agencies on biological manufacturing programs.
Competitive Landscape 2025–2026
In 2025, Ginkgo has undergone significant restructuring after its SPAC valuation proved unsustainably high relative to revenue growth. The company announced major layoffs of over 50% of its workforce in 2023-2024 and sold or wound down several subsidiary businesses to reduce cash burn. Revenue has been concentrated in government biosecurity contracts (Ginkgo Biosecurity) rather than commercial synthetic biology, raising questions about the commercial viability of its original platform vision. Ginkgo's 2025-2026 survival strategy focuses on right-sizing costs, expanding government biosecurity revenue, and identifying the core platform capabilities worth preserving.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Ginkgo Bioworks is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Zeffy
Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs
Oda Studio
Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Compare Ginkgo Bioworks with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Ginkgo Bioworks? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Ginkgo Bioworks Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ginkgo Bioworks vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →